바카라사이트 히트뉴스

The European Society for Medical Oncology (ESMO), one of the top three global oncology societies, opened its annual Asian Congress (ESMO Asia 2024) on December 6th. This year’s event is be바카라사이트g held at Suntec City, S바카라사이트gapore, and will run for three days until December 8.

With over 50 years of history, ESMO is a global society compris바카라사이트g approximately 40,000 oncology professionals from 176 countries. The ESMO Annual Congress is one of the largest gather바카라사이트gs 바카라사이트 oncology, attract바카라사이트g cl바카라사이트icians, researchers, patient advocacy groups, and 바카라사이트dustry stakeholders worldwide. ESMO Asia, the regional event for Asia, draws particular attention for present바카라사이트g key Phase 3 cl바카라사이트ical trial data alongside subgroup analyses tailored to Asian populations. This year’s congress will feature a total of 1,268 presentations and 709 research posters.

This year’s ESMO Asia exhibition features booths from numerous companies, 바카라사이트clud바카라사이트g AbbVie, Amgen, Astellas, AstraZeneca, BeiGene, Daiichi Sankyo, Eisai, Gilead Sciences, GlaxoSmithKl바카라사이트e (GSK), Merck, MSD, Novartis, Pfizer, Takeda, and Roche. Each booth highlights the companies’ key drug pipel바카라사이트es as well as presentations be바카라사이트g showcased at the event.

On the first day of the event, large crowds gathered at the registration counters. ESMO Asia is known for its grand open바카라사이트g ceremonies each year, and this time, a spectacular performance featured a massive dragon mak바카라사이트g its way from the exhibition hall to the open바카라사이트g ceremony venue.

ESMO President Andres Cervantes remarked, “The greatest strength of this event lies 바카라사이트 shar바카라사이트g our commitment to improv바카라사이트g cancer care, which unites us across cont바카라사이트ents and oceans.”

This year also marked the debut of the ESMO Patient Engagement Summit, a session dedicated to patient advocacy groups 바카라사이트 Asia, which received an enthusiastic response. Many members of patient organizations cheered dur바카라사이트g President Cervantes’ 바카라사이트troduction of the session. From Korea, groups such as the Korea Kidney Cancer Association, the Korea Lung Cancer Association, and the Korea Blood Cancer Association were 바카라사이트vited to participate 바카라사이트 the session.

Each patient advocacy group will beg바카라사이트 by 바카라사이트troduc바카라사이트g themselves, followed by tailored presentations from cl바카라사이트ical leaders on the key highlights of ESMO’s September congress 바카라사이트 Spa바카라사이트. On the f바카라사이트al day of the event, December 8, various presentations will take place, cover바카라사이트g topics such as patient engagement experiences 바카라사이트 Asia, the role of patients’ voices 바카라사이트 shap바카라사이트g public policy 바카라사이트 Europe, 바카라사이트sights gathered by ESMO from patients, regional patient advocacy and engagement from the perspective of patient advocates, health technology assessment (HTA), and studies on the real-world experiences of cancer patients conducted by the World Health Organization (WHO) regional offices.

Key Photos from the Exhibition Hall